breast cancer and glp 1 drugs GLP-1 cut risk by 30%? Not so fast glp-1 and breast cancer GLP-1
Description
On its own, phentermine produces modest weight loss of 3-5% of body weight
Lebrun, L
Tirzepatide is a promising drug for patients with T2DM who also have hypertension and hyperlipidemia
We are now at an inflection point for The Broadening of GLP-1 use, which will extend beyond US-based early adopters to date, to larger numbers of patients globally, Morgan Stanley analysts wrote this year
So far, liraglutide and semaglutide alone have 20 million patient years of exposure
J Clin Neurosci 95:172179
